Blog
How Much Upside is Left in a.k.a. Brands (AKA)? Wall Street Analysts Think 84.68%
a.k.a. Brands (AKA) closed the last trading session at $11.1, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Does VAREX IMAGING (VREX) Have the Potential to Rally 71.44% as Wall Street Analysts Expect?
Shares of VAREX IMAGING (VREX) have gained 23.2% over the past four weeks to close the last trading session at $9.77, but there could still be a solid upside left in the stock if short-term price
Wall Street Analysts Predict a 76.37% Upside in AxoGen (AXGN): Here's What You Should Know
Shares of AxoGen (AXGN) have gained 16.6% over the past four weeks to close the last trading session at $14.01, but there could still be a solid upside left in the stock if short-term price targets
Wall Street Analysts Predict a 25.69% Upside in Embecta Corp. (EMBC): Here's What You Should Know
Embecta Corp. (EMBC) closed the last trading session at $12.73, gaining 22.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Here's Why German American Bancorp (GABC) Is a Great 'Buy the Bottom' Stock Now
A downtrend has been apparent in German American Bancorp (GABC) lately. While the stock has lost 6.8% over the past four weeks, it could witness a trend reversal as a hammer chart pattern was formed
Here's Why CB Financial Services (CBFV) Is a Great 'Buy the Bottom' Stock Now
A downtrend has been apparent in CB Financial Services (CBFV) lately. While the stock has lost 5.3% over the past two weeks, it could witness a trend reversal as a hammer chart pattern was formed in
How Much Upside is Left in Enerflex (EFXT)? Wall Street Analysts Think 28.79%
Enerflex (EFXT) closed the last trading session at $9.17, gaining 13.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Zymeworks (ZYME) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
The price trend for Zymeworks Inc. (ZYME) has been bearish lately and the stock has lost 7.6% over the past two weeks. However, the formation of a hammer chart pattern in its last trading session
Rapt Therapeutics (RAPT)'s Technical Outlook is Bright After Key Golden Cross
After reaching an important support level, Rapt Therapeutics (RAPT) could be a good stock pick from a technical perspective. RAPT recently experienced a "golden cross" event, which saw its 50-day
Q2 in the Rearview: Is COP a Smart Hold Stock or a Hot Chase?
Last Thursday, ConocoPhillips COP reported second-quarter 2025 earnings, which exceeded expectations. This was driven by higher oil-equivalent production volumes, especially from the Lower 48, which
How Should You Play RTX Stock Following Its DARPA Contract Win?
RTX Corp.’s (RTX) BBN Technologies company has recently secured a DARPA contract for the Intelligent Generation of Tools for Security program, aimed at strengthening cybersecurity by automating the
Cheniere Energy Lands New LNG Supply Deal With JERA Starting 2029
Cheniere Energy Inc. LNG has signed a long-term sales and purchase agreement (SPA) with JERA, a Japanese energy firm, for the supply of liquefied natural gas. The deal was secured by Cheniere
LRCX's ALD Moly Adoption Ramps Up: Will it be a Key Growth Driver?
Lam Research LRCX is growing its position in molybdenum (moly) deposition, a technology that could increase its share of the chip equipment market. Lam Research is currently the only supplier with
Why Verizon Communications (VZ) is a Top Momentum Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research
Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research
Why Monster Beverage (MNST) is a Top Momentum Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research
Why Annaly Capital Management (NLY) is a Top Momentum Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The popular research
Why RingCentral (RNG) is a Top Momentum Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service
Why Envista (NVST) is a Top Momentum Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research
Why Eversource Energy (ES) is a Top Momentum Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The research service
Why Conmed (CNMD) is a Top Momentum Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Will Appliance & Building Material Sales Keep Lifting Home Depot's Q2?
The Home Depot, Inc.’s HD first-quarter fiscal 2025 results revealed pockets of growth in an otherwise challenging environment. While total comparable sales slipped 0.3%, six of the retailer’s
Philip Morris' ILUMA Rollout: Will It Power H2 Volume Growth?
Philip Morris International (PM) is leaning on its ILUMA platform to keep heated tobacco unit (“HTU”) momentum rolling into the back half of 2025. In the second quarter of 2025, adjusted in-market



